Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NutriBand (NTRB) Gains from Investment Securities (2018 - 2025)

Historic Gains from Investment Securities for NutriBand (NTRB) over the last 8 years, with Q4 2025 value amounting to $1.5 million.

  • NutriBand's Gains from Investment Securities fell 7408.54% to $1.5 million in Q4 2025 from the same period last year, while for Oct 2025 it was $1.5 million, marking a year-over-year decrease of 7408.54%. This contributed to the annual value of $1.4 million for FY2025, which is 5702.02% up from last year.
  • As of Q4 2025, NutriBand's Gains from Investment Securities stood at $1.5 million, which was down 7408.54% from $1.4 million recorded in Q3 2025.
  • NutriBand's Gains from Investment Securities' 5-year high stood at $5.6 million during Q4 2024, with a 5-year trough of $3331.0 in Q4 2021.
  • Its 5-year average for Gains from Investment Securities is $1.5 million, with a median of $646734.0 in 2021.
  • In the last 5 years, NutriBand's Gains from Investment Securities crashed by 9765.14% in 2021 and then surged by 1839332.67% in 2024.
  • Quarter analysis of 5 years shows NutriBand's Gains from Investment Securities stood at $3331.0 in 2021, then skyrocketed by 3083.16% to $106031.0 in 2022, then soared by 281.49% to $404500.0 in 2023, then skyrocketed by 1283.93% to $5.6 million in 2024, then crashed by 74.09% to $1.5 million in 2025.
  • Its Gains from Investment Securities stands at $1.5 million for Q4 2025, versus $1.4 million for Q3 2025 and $1.4 million for Q2 2025.